Acorda Therapeutics Inc (ACORQ)
0.85
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Acorda Therapeutics Gross Profit Margin (Quarterly): 85.26% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.26% |
| September 30, 2023 | 87.78% |
| June 30, 2023 | 89.67% |
| March 31, 2023 | 85.47% |
| December 31, 2022 | 85.51% |
| September 30, 2022 | 67.16% |
| June 30, 2022 | 71.66% |
| March 31, 2022 | 73.52% |
| December 31, 2021 | 88.64% |
| September 30, 2021 | 57.71% |
| June 30, 2021 | 64.37% |
| March 31, 2021 | 58.56% |
| December 31, 2020 | 71.59% |
| September 30, 2020 | 77.08% |
| June 30, 2020 | 80.20% |
| March 31, 2020 | 86.32% |
| December 31, 2019 | 82.84% |
| September 30, 2019 | 83.27% |
| June 30, 2019 | 81.23% |
| March 31, 2019 | 80.06% |
| December 31, 2018 | 68.94% |
| September 30, 2018 | 82.39% |
| June 30, 2018 | 80.18% |
| March 31, 2018 | 80.56% |
| December 31, 2017 | 85.86% |
| Date | Value |
|---|---|
| September 30, 2017 | 78.63% |
| June 30, 2017 | 78.61% |
| March 31, 2017 | 78.77% |
| December 31, 2016 | 78.41% |
| September 30, 2016 | 79.50% |
| June 30, 2016 | 79.14% |
| March 31, 2016 | 79.86% |
| December 31, 2015 | 79.71% |
| September 30, 2015 | 83.20% |
| June 30, 2015 | 79.89% |
| March 31, 2015 | 81.37% |
| December 31, 2014 | 78.68% |
| September 30, 2014 | 80.43% |
| June 30, 2014 | 80.38% |
| March 31, 2014 | 80.52% |
| December 31, 2013 | 79.98% |
| September 30, 2013 | 79.54% |
| June 30, 2013 | 80.36% |
| March 31, 2013 | 81.02% |
| December 31, 2012 | 79.92% |
| September 30, 2012 | 80.73% |
| June 30, 2012 | 81.85% |
| March 31, 2012 | 82.28% |
| December 31, 2011 | 81.29% |
| September 30, 2011 | 69.30% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
57.71%
Minimum
Sep 2021
89.67%
Maximum
Jun 2023
77.78%
Average
81.23%
Median
Jun 2019
Gross Profit Margin (Quarterly) Benchmarks
| BioSig Technologies Inc | -- |
| Verve Therapeutics Inc | -- |
| Spectral AI Inc | 42.79% |
| AIM ImmunoTech Inc | 81.54% |
| Protalix BioTherapeutics Inc | 15.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -906.6% |
| Return on Assets | -78.52% |
| Return on Invested Capital | -123.8% |
| Profit Margin (Quarterly) | -573.3% |
| Operating Margin (Quarterly) | 3.90% |
| Return on Net Operating Assets | -90.47% |